Trial Profile
Clinical Trials Insight: 700034314
Status:
Not yet recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 09 Jun 2008
Price :
$35
*
At a glance
- Drugs Treprostinil (Primary)
- Indications Pulmonary hypertension
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Aradigm Corporation; Lung Biotechnology
- 09 Jun 2008 New trial record.